- The study addressed the poorly understood roles of common and rare genetic variations in postpartum psychosis.
- Researchers analyzed data from Swedish national registers and 240,009 samples from the All of Us Research Program.
- They found a family-based heritability of 55% and identified DNMT1 and HMGCR as potential risk genes (q < 0.1).
- The authors concluded these findings reveal unique genetic contributions and shared pathways in postpartum psychosis.
- This genetic insight provides a foundation for understanding pathophysiology and advancing therapeutic strategies for patients.
*New research quantifies genetic contributions to postpartum psychosis and identifies specific genes, including shared pathways with other psychiatric *
Unraveling the Genetic Landscape of Postpartum Psychosis
Postpartum psychosis is a psychiatric emergency, marked by the abrupt onset of psychosis, mania, or severe depression after childbirth, with profound consequences for maternal and infant health [1]. While its clinical presentation is distinct from more common conditions like postpartum depression, and a strong genetic component has long been suspected, the specific genetic architecture has remained poorly defined [1, 2, 3, 4]. Previous work has established heritability for other major psychiatric disorders, but the underpinnings of postpartum psychosis have been less clear [5, 6, 7]. A recent large-scale study provides new clarity, quantifying the genetic contribution through two different methods. The researchers estimated the family-based heritability, which reflects the overall risk running in families, at 55%. They also calculated the heritability based on whole-genome sequencing (WGS) data from a broader population, which measures the contribution of common genetic variants, at 37% [8].
X Chromosome Link and Specific Gene Candidates Emerge
Moving beyond broad heritability estimates, the investigation uncovered more specific features of the condition's genetic landscape. The analysis revealed an overrepresentation of genetic risk factors on the X chromosome, a finding that points toward a potential sex-linked biological mechanism, which is particularly relevant for a condition exclusively affecting individuals after childbirth. This insight helps narrow the search for the molecular drivers of the disorder. To identify specific genes, the researchers employed rare coding variant analysis, a technique that focuses on uncommon mutations within the protein-building instructions of DNA. This approach pinpointed two candidate risk genes: DNMT1 and HMGCR. These associations were statistically robust, identified with a q-value less than 0.1, a threshold that corrects for multiple comparisons to reduce the likelihood of false positives. The identification of these specific genes provides concrete molecular targets for future research into the pathophysiology of postpartum psychosis and may guide the development of more precise diagnostic or therapeutic strategies.
Shared Genetic Vulnerabilities Across Psychiatric and Autoimmune Conditions
To assess the broader biological relevance of these findings, the authors examined the identified genes, DNMT1 and HMGCR, in a massive independent dataset. An analysis of 240,009 samples from the All of Us Research Program confirmed significant associations between these genes and multiple other psychiatric disorders, suggesting they are involved in pathways of mental illness that extend beyond the postpartum period. This cross-validation strengthens the case for their role in neuropsychiatric function. The study also explored the extent to which the overall genetic risk for postpartum psychosis overlaps with other conditions. The findings revealed a substantial shared genetic architecture: 17% of known bipolar disorder risk genes also conferred risk for postpartum psychosis, and 21% of schizophrenia risk genes overlapped. This genetic convergence may help explain the clinical similarities in mood and psychotic symptoms. Furthermore, the analysis identified a notable link to immune function, with 16% to 25% of risk genes for multiple autoimmune disorders also overlapping with postpartum psychosis, suggesting that immune dysregulation may be a component of its pathophysiology.
Implications for Pathophysiology and Future Therapies
By integrating data from Swedish national registers with genomic information from the All of Us Research Program, this study constructs a more detailed genetic map of postpartum psychosis. The combination of high heritability estimates (55% family-based, 37% WGS-based), an X chromosome linkage, and the identification of specific candidate genes like DNMT1 and HMGCR (q < 0.1) reveals unique genetic contributions that distinguish the condition. These results provide tangible biological clues that move the field beyond clinical observation toward a mechanistic understanding. Moreover, the demonstrated genetic overlap with other major disorders provides critical context. The finding that 17% of bipolar disorder risk genes, 21% of schizophrenia risk genes, and 16-25% of autoimmune disorder risk genes are shared with postpartum psychosis indicates that the condition does not arise from an entirely isolated biological pathway. This knowledge provides a crucial foundation for understanding the pathophysiology of postpartum psychosis. Ultimately, these insights into both unique and shared genetic factors are essential for advancing therapeutic strategies, opening avenues for research into targeted interventions that address the specific molecular drivers of the illness.
References
1. Yim IS, Stapleton LRT, Guardino CM, Hahn‐Holbrook J, Schetter CD. Biological and Psychosocial Predictors of Postpartum Depression: Systematic Review and Call for Integration. Annual Review of Clinical Psychology. 2015. doi:10.1146/annurev-clinpsy-101414-020426
2. Couto TCE. Postpartum depression: A systematic review of the genetics involved. World Journal of Psychiatry. 2015. doi:10.5498/wjp.v5.i1.103
3. Tambelli R, Tosto S, Favieri F. Psychiatric Risk Factors for Postpartum Depression: A Systematic Review. Behavioral Sciences. 2025. doi:10.3390/bs15020173
4. Rees S, Channon S, Waters CS. The impact of maternal prenatal and postnatal anxiety on children’s emotional problems: a systematic review. European Child & Adolescent Psychiatry. 2018. doi:10.1007/s00787-018-1173-5
5. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. 2018. doi:10.1111/bdi.12609
6. Yuan M, Yang B, Rothschild G, et al. Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. Signal Transduction and Targeted Therapy. 2023. doi:10.1038/s41392-023-01519-z
7. Castellini G, Merola GP, Boy OB, et al. Emotional dysregulation, alexithymia and neuroticism: a systematic review on the genetic basis of a subset of psychological traits. Psychiatric Genetics. 2022. doi:10.1097/ypg.0000000000000335
8. Jung S, Caballero M, Kępińska A, et al. Genetic Architecture of Postpartum Psychosis: From Common to Rare Genetic Variation.. medRxiv : the preprint server for health sciences. 2024. doi:10.1101/2024.12.09.24318732